Saw a post somewhere that said Jeffries Financial Services

New Post Public Reply Private Reply Replies (2) Message Board
petemantx
617
Saw a post somewhere that said Jeffries Financial Services estimated that a full blown effective Covid therapeutic would be worth $10B/yr.

I bring this to light just to show why this investment has been so Dr Jekyll and Mr Hyde. Though it seems like we long term investors have been in a living hell over the last number of years (maybe up to 7 years) it also has been a Mr Hyde in foreshadowing a possible windfall that could change all of our lives financially.

The highs and lows have been extreme but how else could many of us even dream of accruing returns that could be in the many tens of millions of dollars?

I still contend we have the "Perfect Storm" for a future of Brilacidin that will be historic, meteoric, and a wonderful gift to mankind.

No matter what, this has been one hell of a ride. The old line we touted years ago of being either "visionaries or fools" is leaning heavily today towards the former in my opinion.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

University Highlights Scholars' Impact on Leadership

Updated Category News Views 5

Navigating the Frontier of Academic Research There's a certain grit to diving headfirst into academia's tricky landscapes, and the University of Phoenix is throwing its cap in the ring with their inaugural President's Award. It's all happening at this virtual jamboree they call the Knowledge Without Boundaries Summit on October 22–23, 2026. They're spotlighting the...

Continue Reading
Short Term Shop Hits $500M in Airbnb Sales Milestone

Updated Category News Views 10

Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...

Continue Reading
Hyliion Faces Legal Drama Over Securities Violations

Updated Category News Views 0

A Stock Tango Entangled in Legal Webs Ah, Hyliion Holdings Corp. (NYSE American: HYLN) finds itself in the legal crosshairs this time around. On October 20, 2026, DJS Law Group sounded the alarm, reminding investors that there’s a class action lawsuit hanging over Hyliion's head like a gray cloud over a picnic. Allegations of securities law violations are the game of...

Continue Reading
Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Updated Category News Views 2

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Continue Reading
Call to Action: Make Disease Cure the Top Election Issue

Updated Category News Views 6

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Continue Reading
Triller's Tangle: Investors Face Massive Stock Drop

Updated Category News Views 5

A Descent into Legal Quagmire Investor action notices usually scream trouble, and this time it’s Triller Group Inc. (NASDAQ: ILLR) taking the brunt. If you haven’t been under a rock, you’ve heard they’re in a spot of bother, courtesy of a gnarly combination of financial mishaps and misleading statements. It’s a classic case of a company shooting itself in the...

Continue Reading
Papa John's Legal Woes: Class Action Lawsuit Hits Hard

Updated Category News Views 5

A Hot Slice of Legal Trouble for Papa John's Ah, what a steaming mess Papa John's seems to have landed in! And not the good kind with extra cheese. The lawsuit bell tolls for them, reminding investors that even the big guys can get burned. This time, it's for allegedly not having their story straight when it came to market expectations and promotional tactics. Under the...

Continue Reading
Gildan Faces Heat: Channel Stuffing Allegations Arise

Updated Category News Views 3

Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...

Continue Reading
Dairy Blends Market Eyes USD 15.38B by 2035 Growth

Updated Category News Views 3

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

Continue Reading
Rondo and Rio Tinto Forge Ahead with Heat Battery Project

Updated Category News Views 4

Taking Energy Storage to New Heights in Australia Sometimes, the energy game looks like a mess of mismatched puzzle pieces, but every now and then, the pieces align perfectly. Here’s Rondo Energy, paired up with Rio Tinto, diving nose-first into a whopper of a project in Gladstone. We’re talking about the largest thermal energy storage undertaking in Australia, a big...

Continue Reading

Top 5 Most Recently Viewed Articles

Karyopharm's SENTRY Trial Gains Momentum with New Endpoint

Updated Category News Views 41

Changes to the Co-Primary Endpoint in the SENTRY Trial Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a pharmaceutical company committed to advancing innovative cancer therapies, has made a crucial adjustment in their Phase 3 SENTRY trial focusing on myelofibrosis. Following valuable feedback from the U.S. Food and Drug Administration (FDA), the company is shifting the...

Continue Reading
First Citizens BancShares Sets Earnings Call for Next Quarter

Updated Category News Views 148

First Citizens BancShares Announces Upcoming Earnings Call First Citizens BancShares, Inc. (NASDAQ: FCNCA) has exciting news to share with its investors. The company has officially announced its plan to report financial results for the fiscal quarter that ended June 30, 2025. The announcement is set to be made before the financial markets open on Friday. Details of the...

Continue Reading
Exciting Talent Search Launches for Upcoming Air Bud Return

Updated Category News Views 188

Cineverse and Air Bud Entertainment Announce National Talent Search One of Hollywood's Most Enduring Family Film Franchises Returns to Theaters in Summer 2026 Cineverse (NASDAQ: CNVS), a next-generation entertainment studio, alongside Air Bud Entertainment, is thrilled to declare the commencement of a nationwide talent search. This initiative seeks to find the next golden...

Continue Reading
Analyzing Apple's Competitive Edge in Technology Hardware Market

Updated Category News Views 193

Examining Apple's Position in Technology Hardware In a fast-evolving technology landscape, a thorough analysis of companies is essential for investors and business enthusiasts. This article will explore Apple Inc. (NASDAQ: AAPL) and how it fits into the dynamic Technology Hardware, Storage & Peripherals industry. By analyzing significant financial ratios and market...

Continue Reading
Vystar Unveils Refreshing New Website and Brand Identity

Updated Category News Views 115

Introducing Vystar’s Revitalized Digital Presence Vystar Corporation (OTCQB: VYST), a leading name in innovative comfort solutions, has taken a bold step forward by launching a freshly redesigned website. With a cleaner look and improved functionality, the new site serves as a vital element of the company's comprehensive digital strategy and brand refresh. Customers can...

Continue Reading